The Family Firm’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $684K | Sell |
|
|||||
|
2024
Q4 | $661K | Buy |
|
|||||
|
2024
Q3 | $708K | Buy |
|
|||||
|
2024
Q2 | $661K | Buy |
|
|||||
|
2024
Q1 | $674K | Sell |
|
|||||
|
2023
Q4 | $639K | Buy |
|
|||||
|
2023
Q3 | $590K | Sell |
|
|||||
|
2023
Q2 | $622K | Sell |
|
|||||
|
2023
Q1 | $636K | Buy |
|
|||||
|
2022
Q4 | $645K | Sell |
|
|||||
|
2022
Q3 | $654K | Sell |
|
|||||
|
2022
Q2 | $750K | Sell |
|
|||||
|
2022
Q1 | $779K | Sell |
|
|||||
|
2021
Q4 | $952K | Buy |
|
|||||
|
2021
Q3 | $885K | Buy |
|
|||||
|
2021
Q2 | $750K | Buy |
|
|||||
|
2021
Q1 | $683K | Buy |
|
|||||
|
2020
Q4 | $706K | Sell |
|
|||||
|
2020
Q3 | $647K | Buy |
|
|||||
|
2020
Q2 | $606K | Buy |
|
|||||
|
2020
Q1 | $476K | Hold |
|
|||||
|
2019
Q4 | $567K | Sell |
|
|||||
|
2019
Q3 | $501K | Buy |
|
|||||
|
2019
Q2 | $413K | Buy |
|
|||||
|
2019
Q1 | $365K | Buy |
|
|||||
|
2018
Q4 | $274K | Buy |
|
|||||
|
2018
Q3 | $325K | Buy |
|
|||||
|
2018
Q2 | $282K | Sell |
|
|||||
|
2018
Q1 | $356K | Buy |
|
|||||
|
2017
Q4 | $271K | Buy |
|